Hedge fund investor tells jurors in Holmes trial that Theranos lied about finger-prick tech and military use
Summary
SAN JOSE, CALIF. -- A hedge fund manager who put $96 million into Theranos said he thoroughly investigated the company but was still misled by CEO Elizabeth Holmes about its blood-testing technology. Brian Grossman, chief investment officer at PFM Health Sciences, told jurors in Holmes criminal trial on Tuesday that in 2014, as part of his due diligence, he got his own blood drawn from a Theranos machine at a Walgreens pharmacy. "I had my blood drawn with a venous draw, not a finger stick," said Grossman, adding that the experience undermined what hed been told about Theranos. Grossman said he met with Holmes and her top executive, Ramesh "Sunny" Balwani, at their office in Palo Alto, California, in December 2013. Earlier witnesses, including lab associate Erika Cheung, have testified that Theranos devices couldnt run more than 12 different tests, contradicting the companys public pronouncements.